Malignant neoplasm of epididymis
ICD-10 C63.0 is a billable code used to indicate a diagnosis of malignant neoplasm of epididymis.
Malignant neoplasm of the epididymis is a rare form of cancer that arises from the epididymis, a coiled tube located at the back of the testis that stores and matures sperm. This neoplasm is classified under male genital malignancies and can present with symptoms such as a painless lump in the scrotum, swelling, or discomfort. Diagnosis typically involves imaging studies such as ultrasound or MRI, and a biopsy is often required to confirm malignancy. The staging of epididymal cancer follows the TNM classification system, assessing tumor size (T), lymph node involvement (N), and metastasis (M). Elevated prostate-specific antigen (PSA) levels may be observed, although PSA is more commonly associated with prostate cancer. Fertility considerations are significant, as treatment options may impact sperm production and overall reproductive health. Patients may require counseling regarding fertility preservation prior to treatment, especially if surgical intervention is necessary.
Detailed clinical notes, imaging results, and pathology reports are essential.
Diagnosis and management of scrotal masses, evaluation of infertility related to malignancy.
Urologists must document the extent of disease and any surgical interventions performed.
Comprehensive treatment plans, staging information, and follow-up care documentation.
Management of malignant neoplasms, chemotherapy regimens, and radiation therapy.
Oncologists should ensure accurate coding of treatment modalities and their impact on fertility.
Performed for malignant neoplasm of the epididymis.
Operative report detailing the procedure and findings.
Urologists must ensure accurate coding of the surgical approach and any complications.
Common symptoms include a painless lump in the scrotum, swelling, and discomfort. Some patients may also experience changes in fertility.
Diagnosis typically involves imaging studies such as ultrasound or MRI, followed by a biopsy to confirm malignancy.
Treatment options may include surgical resection, chemotherapy, and radiation therapy, depending on the stage and grade of the tumor.
